EYLEA® HD (aflibercept) Injection 8 mg Two-year Results from Pivotal PULSAR Trial in Wet Age-related Macular Degeneration Presented at EURETINA
First presentation of long-term results demonstrated sustained visual and anatomic improvements among EYLEA HD patients through two years TARRYTOWN,...
Wall Street Stock Report
We are a Wall Street platform for public companies, investors, and traders. We are committed to building an investment community platform, providing public companies a forum to network with investors from different institutions that invest in multiple sectors.
